Koyfin Home > Directory > Health Care > Adamas Pharma > Other Liabilities

Adamas Pharma Other Liabilities Chart (ADMS)

Adamas Pharma annual/quarterly Other Liabilities from 2013 to 2020.
  • Adamas Pharma Other Liabilities for the quarter ending June 06, 2020 was $3m a 36.84% increase of 1m year over year
  • Adamas Pharma Other Liabilities for the last 12 months ending June 06, 2020 was $3m a 36.84% increase of 1m year over year
  • Adamas Pharma Annual Other Liabilities for 2019 was $2m a -48.17% decrease of -1m from 2018
  • Adamas Pharma Annual Other Liabilities for 2018 was $3m a 75.09% increase of 2m from 2017
  • Adamas Pharma Annual Other Liabilities for 2017 was $1m a 31.28% increase of 0m from 2016
Other Balance Sheet Metrics:
  • Adamas Pharma Total Assets for the quarter ending September 09, 2018 was $257m a 27.59% increase of 71m year over year
  • Adamas Pharma Total Equity for the quarter ending September 09, 2018 was $114m a 42.20% increase of 48m year over year
View Chart On Koyfin

Quarterly ADMS Other Liabilities Data

06/2020$3m
03/2020$2m
12/2019$2m
09/2019$2m
06/2019$2m
03/2019$1m
12/2018$3m
09/2018$2m
06/2018$1m
03/2018$1m

Annual ADMS Other Liabilities Data

2019$2m
2018$3m
2017$1m
2016$1m
2015$1m
2014$2m
2013$0m
2011$0m